supported by grants from the National Science Foundation of Guangdong Province (No. S2013040014088);the Postdoctoral Science Foundation of Guangzhou City (Q188);partially supported by the Guangdong Major Scientific and Technological Special Project for New Drug Development (2013A022100029)
Chiral drug naftopidil(NAF), a specific α1D-adrenoceptor(AR) antagonist for the treatment of benign prostatic hyperplasia, was used in racemic form for several decades. Our recent work declared that NAF enantiomers s...
Guangzhou mega Projects of Science Research in 2009(Grant No.2009A1-E011-7)
Effective enantioseparation of Naftopidil and its derivatives by HPLC was accomplished using several different polysaccharide-based chiral stationary phases(CSPs).In normal-phase mode,the compounds were eluted on fo...
To improve the bioavailability of naftopidil, bioadhesive sustained-release capsules and nonbioadhesive capsules were prepared. Bioadhesive polymers such as hydroxypropyl methylcellulose (HPMC) and Carbopol 934 (CP 93...